Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02117219
Title Phase 1 Study to Evaluate MEDI4736 in MDS
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | DEU

Facility Status City State Zip Country Details
Research Site Scottsdale Arizona 85259 United States Details
Research Site Los Angeles California 90095 United States Details
Research Site New Haven Connecticut 06520-8063 United States Details
Research Site Tampa Florida 33612 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Chicago Illinois 60637 United States Details
Research Site Baltimore Maryland 21201 United States Details
Research Site Boston Massachusetts 02215 United States Details
Research Site Detroit Michigan 48201 United States Details
Research Site Rochester Minnesota 55905 United States Details
Research Site New York New York 10029 United States Details
Research Site New York New York 10065 United States Details
Research Site Greenville South Carolina 29601 United States Details
Research Site Houston Texas 77030 United States Details
Research Site San Antonio Texas 78229 United States Details
Research Site Milwaukee Wisconsin 53226 United States Details
Research Site Paris Cedex 10 75475 France Details
Research Site Dresden 1307 Germany Details
Research Site Brighton BN2 5BE United Kingdom Details
Research Site London SE5 9RS United Kingdom Details
Research Site Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field